Skip to Content

brentuximab vedotin

 

Definition: An antineoplastic agent used in CD30-positive neoplasms consisting of a chimeric monoclonal antibody directed against CD30 linked to the antimitotic toxic agent monomethyl auristatin E via a cleavable linker.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.

Hide